Liquidia
Commercializes inhaled treprostinil therapies for pulmonary hypertension and develops twice-daily L606.
$68.25
After-hours close+0.59 (+0.87%)
At close$67.66(−3.26%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 88.88%Insiders 15.91%
Institutions and insiders are filed separately and overlap, so together they can pass the whole company. No split is drawn from them.
Shares outstanding 88.93M · Float 62.33M · 70.1% free float
Institutions13F, as of Jun 30, 2026
365 holders · 79.04M shares · 130 new positions · 236 increased · 83 reduced · 38 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 10.79M | 12.13% | +5.30M | Aug 7, 2026 |
| Farallon Capital Management LLC | 8.37M | 9.41% | −291.0K | Aug 14, 2026 |
| Caligan Partners LP | 8.12M | 9.13% | 0 | Aug 14, 2026 |
| Findell Capital Management LLC | 3.50M | 3.94% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 3.14M | 3.53% | +212.2K | Aug 13, 2026 |
| State Street Corp | 3.03M | 3.41% | +1.15M | Aug 7, 2026 |
| Opaleye Management Inc. | 2.45M | 2.75% | −97.5K | Aug 14, 2026 |
| Geode Capital Management, LLC | 2.12M | 2.39% | +192.3K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.00% | 4.21M | Nov 8, 2024 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Caligan Partners LP | director, 10 percent owner, other: See Remarks | 8.13M | 9.15% | May 20, 2026 |
| Roger Jeffs | director, officer: Chief Executive Officer | 2.17M | 2.44% | Jul 14, 2026 |
| Paul B. Manning | director | 1.19M | 1.34% | Jun 18, 2026 |
| Russell Schundler | officer: General Counsel | 606.0K | 0.68% | Jul 14, 2026 |
| Stephen M. Bloch | director | 573.1K | 0.64% | Jul 24, 2026 |
| Michael Kaseta | officer: CFO and COO | 345.8K | 0.39% | Jul 14, 2026 |
| Scott Moomaw | officer: Chief Commercial Officer | 182.5K | 0.21% | Jul 14, 2026 |
| Jason Adair | officer: Chief Business Officer | 174.6K | 0.20% | Aug 25, 2026 |
| Dana Boyle | officer: Chief Accounting Officer | 167.9K | 0.19% | Jul 29, 2026 |
| Rajeev Saggar | officer: Chief Medical Officer | 142.3K | 0.16% | Aug 19, 2026 |
21 ten-percent owners hold 12.81M shares by Form 4, outside the officers-and-directors figure above · 9 people have not refiled in the last 18 months (549.1K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 21, 2026 | Jason Adairofficer: Chief Business Officer | Sale · 2 lots | 73,631 | $69.09 | 174,606 |
| Aug 20, 2026 | Katherine Rielly-Gauvindirector | Sale | 18,393 | $72.23 | 44,637 |
| Aug 19, 2026 | Katherine Rielly-Gauvindirector | Sale | 36,789 | $74.99 | 44,637 |
| Aug 19, 2026 | Rajeev Saggarofficer: Chief Medical Officer | Sale | 50,000 | $74.06 | 142,265 |
| Aug 17, 2026 | Rajeev Saggarofficer: Chief Medical Officer | Sale | 29,534 | $76.84 | 142,265 |
| Jul 27, 2026 | Jason Adairofficer: Chief Business Officer | Sale | 688 | $87.53 | 216,438 |
| Jul 27, 2026 | Dana Boyleofficer: Chief Accounting Officer | Sale | 1,600 | $87.53 | 167,919 |
| Jul 23, 2026 | Stephen M. Blochdirector | Sale · 2 lots | 100,000 | $89.48 | 501,477 |
| Jul 22, 2026 | Stephen M. Blochdirector | Sale · 3 lots | 100,000 | $88.38 | 601,477 |
| Jul 21, 2026 | Stephen M. Blochdirector | Sale · 2 lots | 75,000 | $79.99 | 701,477 |
CongressHouse and Senate disclosures
Not reported.